NURODIN Inj. (Tagamet)
DOH PM 026562
< Composition >
Each ml contains:
Cimetidine.........................150mg
< Action >
Nurodin is a specific competitive H2 receptor antagonist without significant interaction at catecholamine B receptors, histamine H1 receptors of muscarinic receptors.
< Indication >
Nurodin is indicated in the short term treatment of duodenal ulcer, gastric ulcer, pathological hypersecretion associated with Zollinger-Ellison syndrome.
< Dosage >
The dose by intravous or intramuscular injection is normally 300 mg. Injection may be repeated at six hourly intervals, the maximum dose of 2400 mg/day. Nurodin for intravenous injection should be diluted in normal saline or in 5% dextrose.
< Package >
2 ml × 100 Amp.